NOVIGENIX AI (NOVIGENIX SA)

Company Snapshot

Founded: 2014
Entity Type: Private
Region: Switzerland
Headquarter: Epalinges, Switzerland
Key Geographics: Switzerland
Corporate Address: Route de la Corniche 3, Phenyl Building CH-1066 Epalinges Switzerland Tel: +41-0-21552-0730 www.novigenix.com

Company Overview

Novigenix is a Swiss-based precision medicine company specializing in Immuno-transcriptomic solutions aimed at early disease detection, the development of therapeutics, and drug target discovery.

The company’s proprietary LITOSeek platform is an AI-driven RNA analysis tool designed to track the immune system's response to disease onset and progression. By integrating multi-omics patient data with advanced machine learning and AI techniques, Novigenix offers actionable insights and precision solutions. Their liquid biopsy products and services cater to the biopharma sector, focusing on the clinical development of new therapies, drug target identification, and early colorectal cancer detection.

Novigenix serves pharmaceutical and biotechnology clients by utilizing the LITOSeek platform to analyze patient clinical data, revealing critical insights into patient response heterogeneity and enabling the development of actionable biomarkers for optimizing novel therapeutic strategies.

NOVIGENIX AI (NOVIGENIX SA) In Reports

Liquid Biopsy with Emphasis on Cancer: Global Markets

Analyse the global liquid biopsy market in cancer by indication, technology, biomarker, and application, with regional forecasts and competitive insights to 2031.

Global Colorectal Cancer Screening and Diagnostics Market

BCC Research Report: Dive into Colorectal Cancer Screening and Diagnostics Market estimates, data is provided for 2021 and 2022 as historical years, 2023 as the base year, and forecasts extend through 2029.

Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets

BCC Research Report: Dive into Liquid Biopsy Research market estimations and trends, using 2023 as the base year and forecasting 2024 through 2029 with a CAGR projection.

Company's Business Segments

  • Products : Immuno Transcriptomics, LITOseek platform, Others
  • Services : Prevention through early detection of cancer, Precision Medicine, Innovative Drug Target Discovery

Applications/End User Industries

  • Healthcare
  • Pharmaceutical
  • Biotechnology
  • Research Institution
  • Life Sciences
AI Sentiment